AVANT CEO To Present at the UBS 2008 Global Life Sciences Conference September 23
18 Settembre 2008 - 10:00PM
Business Wire
AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) today announced that
Anthony S. Marucci, Interim President and Chief Executive Officer
of AVANT Immunotherapeutics, Inc., will present at the UBS 2008
Global Life Sciences Conference at the Grand Hyatt New York on
Tuesday, September 23, at 2:30 pm, EDT. A live only audio webcast
of the 30-minute presentation will be available in the Investor
Information area of AVANT�s website at http://avantimmune.com. The
audio only webcast will also be available online at the UBS
Investment Bank website. Go to www.ibb.ubs.com. Find the
"Conferences" icon in the center right of the page, click on icon,
and follow the link for Webcast next to the "Global Life Sciences"
Conference heading. An archive of the webcast will be available
three hours following the event for approximately one month. About
AVANT Immunotherapeutics, Inc. AVANT Immunotherapeutics is an
integrated biopharmaceutical company that applies its comprehensive
Precision Targeted Immunotherapy Platform to generate a pipeline of
candidates to treat cancer and other difficult-to-treat diseases.
AVANT�s immunotherapy platform includes a complementary portfolio
of monoclonal antibodies, antibody-targeted vaccines and
immunomodulators to create novel disease-specific drug candidates.
For more information, please visit http://www.avantimmune.com.
Grafico Azioni Avant Immunotherapeutics (MM) (NASDAQ:AVAN)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Avant Immunotherapeutics (MM) (NASDAQ:AVAN)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Avant Immunotherapeutics (MM) (NASDAQ): 0 articoli recenti
Più AVANT Immunotherapeutics, Inc. Articoli Notizie